BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11851621)

  • 21. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues.
    Monstein HJ; Fransén K; Dimberg J; Söderkvist P
    Eur J Clin Invest; 2004 Feb; 34(2):100-6. PubMed ID: 14764072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
    Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of interleukin-6 in the induction of hypercalcemia in renal cell carcinoma transplanted into nude mice.
    Weissglas MG; Schamhart DH; Löwik CW; Papapoulos SE; Theuns HM; Kurth KH
    Endocrinology; 1997 May; 138(5):1879-85. PubMed ID: 9112382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercalcaemia due to parathyroid hormone-related protein: long-term circulating levels may not reflect tumour activity.
    Savage MW; Fraser WD; Bodmer CW; Ginty AF; Gallagher JA; Robinson J; Williams G
    Clin Endocrinol (Oxf); 1993 Dec; 39(6):695-8; discussion 699. PubMed ID: 8287589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours.
    Southby J; O'Keeffe LM; Martin TJ; Gillespie MT
    Br J Cancer; 1995 Sep; 72(3):702-7. PubMed ID: 7669584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercalcemia in a patient with renal cell carcinoma producing parathyroid hormone-related protein and interleukin-6.
    Ueno M; Ban S; Nakanoma T; Tsukamoto T; Nonaka S; Hirata R; Iida M; Deguchi N
    Int J Urol; 2000 Jun; 7(6):239-42. PubMed ID: 10843457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
    Aklilu F; Park M; Goltzman D; Rabbani SA
    Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia.
    Currie MJ; Gunningham SP; Turner K; Han C; Scott PA; Robinson BA; Chong W; Harris AL; Fox SB
    J Pathol; 2002 Dec; 198(4):502-10. PubMed ID: 12434420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating forms of immunoreactive parathyroid hormone-related protein for identifying patients with humoral hypercalcemia of malignancy: a comparative study with C-terminal(109-141)- and N-terminal(1-86)-region-specific PTHrP radioassay.
    Suehiro M; Murakami M; Fukuchi M
    Ann Nucl Med; 1994 Nov; 8(4):231-7. PubMed ID: 7702967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid hormone/parathyroid hormone-related protein receptor expression in nude mice with a transplantable canine apocrine adenocarcinoma (CAC-8) and humoral hypercalcaemia of malignancy.
    Gröne A; McCauley LK; Capen CC; Rosol TJ
    J Endocrinol; 1997 Apr; 153(1):123-9. PubMed ID: 9135577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
    Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
    J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.
    Betsunoh H; Fukuda T; Anzai N; Nishihara D; Mizuno T; Yuki H; Masuda A; Yamaguchi Y; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
    BMC Cancer; 2013 Oct; 13():509. PubMed ID: 24168110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma.
    Wu TJ; Lin CL; Taylor RL; Kvols LK; Kao PC
    Mayo Clin Proc; 1997 Dec; 72(12):1111-5. PubMed ID: 9413289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
    Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
    Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTHrP release in human cancer cells causing humoral hypercalcemia.
    Kasono K; Isozaki O; Sato K; Sato Y; Shizume K; Ohsumi K; Demura H
    Jpn J Cancer Res; 1991 Sep; 82(9):1008-14. PubMed ID: 1938595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of imatinib mesylate for favorable control of hypercalcemia mediated by parathyroid hormone-related protein in a patient with chronic myelogenous leukemia at blast phase.
    Miyoshi N; Tanaka H; Ito T; Katayama Y; Niimi H; Hyodo H; Kimura A
    Int J Hematol; 2005 Nov; 82(4):333-7. PubMed ID: 16298826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid hormone-related peptide is a downstream target for ras and src activation.
    Li X; Drucker DJ
    J Biol Chem; 1994 Mar; 269(9):6263-6. PubMed ID: 8119972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.